Distinguished Experts and Colleagues:

In pursuit of strengthening academic exchanges in the global hematology field, facilitating the in-depth advancement of basic research, translational studies, and clinical investigations related to hematology, and providing a professional platform for knowledge sharing among hematology practitioners, we are delighted to announce that the 2026 Conference on Clinical and Translational Hematology will be held in Xi'an, Shaanxi, China from Sep. 18^th to 19^th, 2026.

This conference is organized by the Chinese Medical Association Publishing House and academically supported by the Chinese Medical Journal, co-hosted by the Second Affiliated Hospital of Xi'an Jiaotong University, The Second Affiliated Hospital of AMU. Professors Xiaojun Huang, Jianxiang Wang, Depei Wu, and Yu Hu shall serve as conference presidents. The executive presidents will be Professors Wanhong Zhao, Xi Zhang and Defu Zeng. The event will focus on the cutting-edge issues in the hematology specialty, gathering renowned experts from both domestic and international hematology research circles to share their latest research breakthroughs and translational achievements.

With more than a century-long history, Chinese Medical Journal (CMJ) is consistently rated as a leading English journal in the second phase of the China Excellence Initiative for Science and Technology Journals. Its 2024 impact factor is 7.3, securing a Q1 ranking and placing it among the top 6.93% globally.

This conference now extends an open call for submissions from hematology medical professionals (first authors) under 45 years old. Outstanding papers will have the opportunity to be presented at this conference and preferentially published in CMJ. Detailed call-for-papers information is provided below.

We sincerely invite you to join us in this event, jointly promoting the development of hematology. Let's converge in Xi'an, to partake in this academic gala and work hand in hand towards a brighter future for hematology.